Dr. Mariângela Batista Galvão Simão, MD - Director-President, All For Health Institute / Instituto Todos pela Saúde (ITpS) - Brazil - Innovation And Equitable Access In Public Health

Progress, Potential, and Possibilities

Dr. Mariângela Simão, MD, MPH is the Director-President of the All For Health Institute ( Instituto Todos pela Saúde - https://www.itps.org.br/ ), a non-profit organization based in São Paulo that focuses on outbreaks, epidemic and pandemic preparedness, in support of the Brazilian health system. Dr. Simão is also a Member of the Supervisory Board of the Access to Medicine Foundation ( https://accesstomedicinefoundation.org/our-team/mariangela-simao ), an organization working to stimulate and guide the pharmaceutical industry to do more for people living in low- and middle-income countries, and recently became a member of the Science & Technology Expert Group (STEG) of the G7 International Pandemic Preparedness Secretariat ( https://ippsecretariat.org/about-us/ ). Dr. Simão attended medical school in Brazil, with degrees in Pediatrics and Public Health, and received a MSc in Mother and Child Health at the University of London, United Kingdom, and she has worked in Brazil’s public health system since 1982, from the primary health care level to a series of managerial positions throughout the years. As a public health professional, at municipal, state and national levels, Dr. Simão played an active role in the decentralization of the national health system, acquiring an extensive experience in health system strengthening. She has also served on the boards of a number of organizations and government committees related to public health and HIV. Between 2006 and 2010, Dr. Simão worked for the Ministry of Health in Brazil as the Director of the Department of Sexually Transmitted Diseases and AIDS. She also worked in the UN Program for HIV and AIDS (UNAIDS) as Director for Prevention, Gender, Community Mobilization and Human Rights for 7 years. Most recently, Dr. Simão was Assistant Director-General for Access to Medicines and Health Products at the WHO from 2017 to 2022.

Support the Show.